UAB PROFARMA has a total of 14 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Lithuania, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology and pharmaceuticals are OSAKA BIO SCI KENKYUSHO, SHANGHAI INST OF ONCOLOGY and NAKAJIMA KUNIO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Lithuania | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Pleckaityte Milda | 10 |
#2 | Zvirblis Gintautas | 10 |
#3 | Mistiniene Edita | 8 |
#4 | Pesliakas Jonas Henrikas | 7 |
#5 | Zvirbliene Aurelija | 5 |
#6 | Zvirblyte Gitana | 2 |
#7 | Pesliakas Henrikas Jonas | 2 |
#8 | Mi Atinienaeu Edita | 2 |
#9 | Kucinskaite-Kodze Indre | 2 |
#10 | Petreikyte Indre | 2 |
Publication | Filing date | Title |
---|---|---|
LT2016100A | Dimeric antibody fragment neutralizing cytolytic activity of vaginolysin | |
LT2013104A | Fused proteins of granulocyte colony-stimulating factor with other partners of growh factor, preferably with stem cell factor, and method of preparation thereof | |
EP2742064A1 | Derivatives of recombinant proteins, homo-multimers of granulocyte colony-stimulating factor and method of preparation thereof | |
LT2010104A | Single stranded recombinant antibody fragment able to neutralize cytolytic activity of vaginolysin | |
LT2010013A | Process for isolating and purifying biologically active g-csf derivatives | |
LT2010012A | Linear oligomers of granulocyte stimulating protein having prolonged survival time | |
LT2009012A | Monoclonal antibodies against vaginolysin |